Stable HIV-1 reservoirs on dolutegravir maintenance monotherapy: the MONODO study.
Delphine SculierT Doco-LecompteS YerlyK J MetznerL A DecosterdA CalmyPublished in: HIV medicine (2018)
In this small sample of carefully selected patients, HIV-1 reservoirs were well controlled on DTG monotherapy over a period of 24 weeks. Viral suppression was also maintained throughout follow-up.
Keyphrases
- antiretroviral therapy
- hiv positive
- hiv infected
- human immunodeficiency virus
- end stage renal disease
- hiv testing
- hepatitis c virus
- hiv aids
- chronic kidney disease
- newly diagnosed
- ejection fraction
- men who have sex with men
- hiv infected patients
- open label
- prognostic factors
- peritoneal dialysis
- randomized controlled trial
- south africa
- clinical trial
- study protocol
- preterm birth